Bioethics commission plays early role in BRAIN Initiative

May 14, 2014

Calling for the integration of ethics across the life of neuroscientific research endeavors, the Presidential Commission for the Study of Bioethical Issues (Bioethics Commission) released volume one of its two-part response to President Obama's request related to the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. The report, Gray Matters: Integrative Approaches for Neuroscience, Ethics, and Society, includes four recommendations for institutions and individuals engaged in neuroscience research including government agencies and other funders.

"Neurological conditions—which include addiction, chronic pain, dementia, depression, epilepsy, multiple sclerosis, Parkinson's disease, schizophrenia, stroke, and traumatic brain injury, among other conditions—affect more than one billion people globally. Neuroscience has begun to make important breakthroughs, but given the complexity of the brain, we must better understand it in order to make desired progress," said Amy Gutmann, Ph.D., Bioethics Commission Chair. "But because research on our brains strikes at the very core of who we are, the ethical stakes of could not be higher. Ethicists and scientists should be together at the table in the earliest stages of research planning fostering a fluent two-way conversation. Too often in our nation's past, ethical lapses in research have had tragic consequences and derailed scientific progress."

President Obama asked the Bioethics Commission to play a critical role in ensuring that neuroscientific investigational methods and protocols are consistent with sound ethical principles and practices. Specifically the President asked the Bioethics Commission to "identify proactively a set of core ethical standards – both to guide research and to address some of the ethical dilemmas that may be raised by the application of neuroscience research findings."

"Our rapidly advancing knowledge of the nervous system – and ability to detect disease sometimes even before symptoms begin – has not yet led to much needed breakthroughs in treatment, repair, and prevention; the BRAIN initiative will hopefully accelerate the trajectory of discoveries against terrible neurologic maladies," Commission Member and neuroimmunologist Stephen Hauser, M.D., said.

In its report the Bioethics Commission noted that when facing the promise of neuroscience, we are compelled to consider carefully scientific advances that have the potential to alter our conception of the very private and autonomous nature of self. Our understanding of the mind, our private thoughts, and our volition necessitates careful reflection about the scientific, societal, and ethical aspects of neuroscience endeavors. Integrating explicitly and systematically into the relatively new field of contemporary neuroscience allows us to incorporate ethical insights into the scientific process and to consider societal implications of neuroscience research from the start. Early ethics integration can prevent the need for corrective interventions resulting from ethical mishaps that erode public trust in science.

"In short, everyone benefits when the emphasis is on integration, not intervention," Gutmann said. "Ethics in science must not come to the fore for the first time after something has gone wrong. An essential step is to include expert ethicists in the BRAIN Initiative advisory and review bodies."

Recommendations

In its report the Bioethics Commission noted that although ethics is already integrated into science in various ways, more explicit and systematic integration serves to elucidate implicit ethical judgments and allows their merits to be assessed more thoughtfully. The Commission offered four recommendations.

  1. Integrate ethics early and explicitly throughout research: Institutions and individuals engaged in neuroscience research should integrate ethics across the life of a research endeavor, identifying the key ethical questions associated with their research and taking immediate steps to make explicit their systems for addressing those questions. Sufficient resources should be dedicated to support ethics integration. Approaches to ethics integration discussed by the Bioethics Commission include:

    a. Implementing ethics education at all levels

    b. Developing institutional infrastructure to facilitate integration

    c. Researching the ethical, legal, and social implications of scientific research

    d. Providing research ethics consultation services

    e. Engaging with stakeholders

    f. Including an ethics perspective on the research team


  2. Evaluate existing and innovative approaches to ethics integration: Government agencies and other research funders should initiate and support research that evaluates existing as well as innovative approaches to ethics integration. Institutions and individuals engaged in neuroscience research should take into account the best available evidence for what works when implementing, modifying, or improving systems for ethics integration.
  3. Integrate ethics and science through education at all levels: Government agencies and other research funders should initiate and support research that develops innovative models and evaluates existing and new models for integrating ethics and science through education at all levels.
  4. Explicitly include ethical perspectives on advisory and review bodies: BRAIN Initiative-related scientific advisory and funding review bodies should include substantive participation by persons with relevant expertise in the ethical and societal implications of the neuroscience research under consideration.

Next the Bioethics Commission will consider the ethical and societal implications of neuroscience research and its applications more broadly – ethical implications that a strongly integrated research and ethics infrastructure will be well equipped to address, and that myriad stakeholders, including scientists, ethicists, educators, public and private funders, advocacy organizations, and the public should be prepared to handle.

Gray Matters: Integrative Approaches for Neuroscience, Ethics, and Society is the Bioethics Commission's seventh report. The Commission seeks to identify and promote policies and practices that ensure that scientific research, health care delivery, and technological innovation are conducted by the United States in a socially and ethically responsible manner. The Commission is an independent, deliberative panel of thoughtful experts that advises the President and the Administration, and, in so doing, educates the nation on bioethical issues. To date the Commission has:

  • Advised the White House on the benefits and risks of synthetic biology;
  • Completed an independent historical overview and ethical analysis of the U.S. Public Health Service STD experiments in Guatemala in the 1940s;
  • Assessed the rules that currently protect human participants in research;
  • Examined the pressing privacy concerns raised by the emergence and increasing use of whole genome sequencing;
  • Conducted a thorough review of the ethical considerations of conducting clinical trials of medical countermeasures with children, including the ethical considerations involved in conducting a pre-and post-event study of anthrax vaccine adsorbed for post-exposure prophylaxis with children; and
  • Offered ethical analysis and recommendations for clinicians, researchers, and direct-to-consumer testing companies on how to manage the increasingly common issue of incidental and secondary findings.

Explore further: US experts urge focus on ethics in brain research (Update)

Related Stories

US experts urge focus on ethics in brain research (Update)

May 14, 2014
Ethics must be considered early and often as the field of modern neuroscience forges ahead, to avoid repeating a dark period in history when lobotomies were common, experts said Wednesday.

Bioethics Commission on incidental findings: Anticipate and communicate

December 12, 2013
Researchers conduct a memory study, scan a participant's brain, and find more than they bargain for: a tumor. What do the researchers owe the participant? What does the participant want to know? This is an increasingly common ...

Considering the ethics of sex-work research

May 2, 2014
The increase of research focusing on sex work and health is not without its ethical concerns. Researchers have sometimes struggled with challenges related to consent, inclusion, privacy and confidentiality, especially working ...

Ethics of peds countermeasure research discussed

March 20, 2013
(HealthDay)—Pediatric research on medical countermeasures should present no more than minimal risk to participants, and should follow a specific framework if there is a minor increase over minimal risk, according to a perspective ...

Improving the quality of clinical ethics consultants

October 7, 2013
Clinical ethicists play a vital role in hospitals and other health care systems by helping to resolve ethical conflicts that arise between patients, families, and clinicians about end-of-life care and other important medical ...

Recommended for you

New map may lead to drug development for complex brain disorders, researcher says

July 24, 2017
Just as parents are not the root of all their children's problems, a single gene mutation can't be blamed for complex brain disorders like autism, according to a Keck School of Medicine of USC neuroscientist.

Working around spinal injuries: Rehabilitation, drug treatment lets rats recover some involuntary movement

July 24, 2017
A new study in rats shows that changes in the brain after spinal cord injury are necessary to restore at least some function to lower limbs. The work was published recently in the journal eLife.

Bird songs provide insight into how developing brain forms memories

July 24, 2017
Researchers at the University of Chicago have demonstrated, for the first time, that a key protein complex in the brain is linked to the ability of young animals to learn behavioral patterns from adults.

Scientists capture first image of major brain receptor in action

July 24, 2017
Columbia University Medical Center (CUMC) researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, ...

Research identifies new brain death pathway in Alzheimer's disease

July 24, 2017
Alzheimer's disease tragically ravages the brains, memories and ultimately, personalities of its victims. Now affecting 5 million Americans, Alzheimer's disease is the sixth leading cause of death in the U.S., and a cure ...

Illuminating neural pathways in the living brain

July 24, 2017
Using light alone, scientists from the Max Planck Institute of Neurobiology in Martinsried are now able to reveal pairs or chains of functionally connected neurons under the microscope. The new optogenetic method, named Optobow, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.